Co-Authors
This is a "connection" page, showing publications co-authored by Hossein Keyvani and Sajad Karampoor.
Connection Strength
2.314
-
A possible pathogenic role of Syndecan-1 in the pathogenesis of coronavirus disease 2019 (COVID-19). Int Immunopharmacol. 2021 Aug; 97:107684.
Score: 0.940
-
Correction to: The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19). Arch Virol. 2021 Jul; 166(7):1841.
Score: 0.238
-
The emerging role of probiotics as a mitigation strategy against coronavirus disease 2019 (COVID-19). Arch Virol. 2021 Jul; 166(7):1819-1840.
Score: 0.234
-
The emerging role of microRNAs in the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Int Immunopharmacol. 2021 Jan; 90:107204.
Score: 0.228
-
Overview of the current promising approaches for the development of an effective severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine. Int Immunopharmacol. 2020 Nov; 88:106928.
Score: 0.225
-
Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020 10; 72(10):2097-2111.
Score: 0.224
-
Coronavirus disease 2019 (COVID-19): Immunological approaches and emerging pharmacologic treatments. Int Immunopharmacol. 2020 Nov; 88:106885.
Score: 0.224